Sang Hyung Lee

Sang Hyung Lee

Auto-generated profile, based on publicly available information

Sang Hyung Lee

Integrative Cancer Center CHA Ilsan Medical Center CHA university

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Integrative Cancer Therapies
Verified
Journal Article
Open access
SHSung-Eun Hong
Sung-Eun Hong
MHMyung Han Hyun
Myung Han Hyun
SLSang Hyung Lee
Sang Hyung Lee
BKBup-Woo Kim
Bup-Woo Kim
HKHee Jun Kim
Hee Jun Kim
JLJee Young Lee
Jee Young Lee
Post-extubastion respiratory symptoms (PERS) are a common sequelae of endotracheal intubation, impeding postoperative recovery. Despite the widespread use of prophylactic corticosteroids and symptomatic management, these approaches have limitations in alleviating PERS. In this study, we aim to evaluate the efficacy and safety of nasal herbal steam therapy (NHST), a traditional Korean medicine intervention, in managing PERS among patients with thyroid cancer following endotracheal intubation. In this pragmatic, parallel-group randomized controlled trial, 66 post-thyroidectomy patients with thyroid cancer who underwent endotracheal intubation will be randomly assigned in a 1:1 ratio to either the NHST group or the standard care group. The intervention group will receive personalized NHST for 5 consecutive days, whereas the control group will follow conventional postoperative care protocols. The primary endpoint is the change in Wisconsin Upper Respiratory Symptom Survey scores from baseline to day 5. Secondary endpoints included patient-reported symptom relief, safety assessments, and adherence rates. By investigating the therapeutic potential of NHST, this study will establish its role as a non-invasive, adjunctive intervention for improving intubation-related complications, potentially contributing to broadening integrative treatment strategies and optimizing recovery outcomes for patients with PERS. The study will be conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of CHA Ilsan Medical Center (ICHA 2024-011-006, date of approval 2024-09-04).

1 March 2025 in Journal of Korean Medicine
Verified
Journal Article
Open access
PDF file
SHSung-Eun Hong
Sung-Eun Hong
MHMyung Han Hyun
Myung Han Hyun
SLSang Hyung Lee
Sang Hyung Lee
BKBup-Woo Kim
Bup-Woo Kim
HKHee Jun Kim
Hee Jun Kim
JLJee Young Lee
Jee Young Lee
Objectives: This study aimed to develop a clinical pathway (CP) for post-operative care in patients with thyroid cancer in integrative medical center setting, specifically targeting the improvement of quality of life (QoL) and clinical management standardization. The CP was refined through a modified Delphi method and subsequently monitored in a clinical setting.Methods: The CP model was based on an analysis of medical records of thyroid cancer patients from July 2022 to February 2024. A time-task matrix was established, categorizing tasks by timeline (pre-operative, operation day, post-operative) and clinical activities (KM (Korean Medicine) evaluation, treatment, activity, diet, education). The draft CP model was validated using the modified Delphi method. Finally, the CP was pilot-tested in a clinical environment monitoring indicators such as CP application rate, completion rate, QoL, and satisfaction levels. To evaluate the CP, THYCA-QoL questionnaire was used, and pain levels were assessed using the Numeric Rating Scale (NRS).Results: The final CP model showed 81.8% application rate and 100% completion rate during the monitoring period. Results of THYCA-QoL questionnaire showed significant improvement in various aspects, including neuromuscula, oral and throat, and psychological issues. The NRS indicated a 48.1% reduction in neck pain intensity after post-CP application. Both patient and medical staff satisfaction increased following the CP's applicationConclusions: The integrative CP model for post-operative care in thyroid cancer patients improved QoL and reduced pain, demonstrating its potential as a standardized tool of integrative cancer healthcare settings. Future studies should refine the model and expand its use to validate efficacy and optimize quality of care.